175 related articles for article (PubMed ID: 208780)
1. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease.
Ullman B; Gudas LJ; Cohen A; Martin DW
Cell; 1978 Jun; 14(2):365-75. PubMed ID: 208780
[No Abstract] [Full Text] [Related]
2. Accumulation of deoxyribonucleotides as a possible mediator of immunosuppression in hereditary deficiency of adenosine deaminase.
Bluestein HG; Willis RC; Thompson LF; Matsumoto S; Seegmiller JE
Trans Assoc Am Physicians; 1978; 91():394-402. PubMed ID: 314193
[No Abstract] [Full Text] [Related]
3. Modulation of adenine nucleoside excretion and incorporation in adenosine deaminase deficient human lymphoma cells.
Iizasa T; Kubota M; Carson DA
Biochem Biophys Res Commun; 1984 Jun; 121(2):514-20. PubMed ID: 6428410
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
[No Abstract] [Full Text] [Related]
5. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
6. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
7. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
9. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
Tsuchiya S; Nakae S; Konno T; Tada K
J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Chan TS; Huang C; Sato T
Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
[TBL] [Abstract][Full Text] [Related]
11. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
[TBL] [Abstract][Full Text] [Related]
12. A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells.
Ullman B; Levinson BB; Hershfield MS; Martin DW
J Biol Chem; 1981 Jan; 256(2):848-52. PubMed ID: 6256370
[No Abstract] [Full Text] [Related]
13. Increased level of ribonucleotide reductase in deoxyadenosine resistant adenosine deaminase deficient human histiocytic lymphoma cells.
Dahbo Y; Carson D; Eriksson S
Adv Exp Med Biol; 1986; 195 Pt B():231-4. PubMed ID: 3532701
[No Abstract] [Full Text] [Related]
14. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
[No Abstract] [Full Text] [Related]
16. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase.
Webster DR; Simmonds HA; Perrett D; Levinsky RJ
Adv Exp Med Biol; 1984; 165 Pt A():363-6. PubMed ID: 6609529
[No Abstract] [Full Text] [Related]
18. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
Chan TS
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
[TBL] [Abstract][Full Text] [Related]
19. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
[TBL] [Abstract][Full Text] [Related]
20. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
